AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Schizophrenia Drugs Market to 2027 - Allergan, Pfizer Inc, Vanda Pharmaceuticals Inc & AstraZeneca Plc - ResearchAndMarkets.com

February 7, 2020 GMT

DUBLIN--(BUSINESS WIRE)--Feb 7, 2020--

The “Schizophrenia Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027” report has been added to ResearchAndMarkets.com’s offering.

Schizophrenia Drugs Market - Scope of the Report

the report on the global schizophrenia drugs market studies the past as well as current growth trends and opportunities, and provides valuable insights of the same indicators for the said market for the forecast period of 2019 to 2027. The report provides the overall market revenue of the global schizophrenia drugs market for the period of 2017 to 2027, with 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global schizophrenia drugs market for the forecast period of 2019 to 2027.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the schizophrenia drugs market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the schizophrenia drugs market.

The report delves into the competitive landscape of the schizophrenia drugs market. Key players operating in the global schizophrenia drugs market are identified, and each one of them are profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT analysis are some of the attributes of the players in the global schizophrenia drugs market profiled in this report.

Key Questions Answered in the Global Schizophrenia Drugs Market Report

Global Schizophrenia Drugs Market - Research Objectives and Research Approach

The comprehensive report on the schizophrenia drugs market begins with an overview of the said market, followed by the scope and objectives of this study. Following this, the report provides detailed explanation of the objectives behind this study, and healthcare compliances laid down by accredited agencies in the purview of the line of treatment of schizophrenia.

Key Topics Covered:

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Schizophrenia Drugs Market

4. Market Overview

4.1. Introduction

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Schizophrenia Drugs Market Analysis and Forecast, 2017-2027

5. Key Insights

5.1. Pipeline Analysis: Schizophrenia Drugs

5.2. Value Chain Analysis

5.3. Global Schizophrenia Drugs Sales Analysis, 2017-2027

6. Global Schizophrenia Drugs Market Analysis and Forecast, by Drug Class

6.1. Introduction & Definitions

6.2. Key Findings / Developments

6.3. Global Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Drug Class, 2017-2027

6.3.1. First Generation Drugs

6.3.2. Second Generation Drugs

6.3.3. Third Generation Drugs

6.4. Global Schizophrenia Drugs Market Attractiveness, by Drug Class

7. Global Schizophrenia Drugs Market Analysis and Forecast, by Route of Administration

7.1. Introduction & Definitions

7.2. Key Findings / Developments

7.3. Global Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Route of Administration, 2017-2027

7.3.1. Injectable

7.3.2. Oral

7.4. Global Schizophrenia Drugs Market Attractiveness, by Route of Administration

8. Global Schizophrenia Drugs Market Analysis and Forecast, by Region

8.1. Key Findings

8.2. Global Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Region

8.3. Global Schizophrenia Drugs Market Attractiveness, by Region

9. North America Schizophrenia Drugs Market Analysis and Forecast

9.1. Introduction

9.2. North America Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Drug Class, 2017-2027

9.3. North America Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Route of Administration, 2017-2027

9.4. North America Schizophrenia Drugs Market Revenue (US$ Mn) Forecast, by Country, 2017-2027

9.5. North America Schizophrenia Drugs Market Attractiveness Analysis

10. Europe Schizophrenia Drugs Market Analysis and Forecast

11. Asia Pacific Schizophrenia Drugs Market Analysis and Forecast

12. Latin America Schizophrenia Drugs Market Analysis and Forecast

13. Middle East & Africa Schizophrenia Drugs Market Analysis and Forecast

14. Competition Landscape

14.1. Global Schizophrenia Drugs Market Share Analysis, by Company (2018)

14.2. Company Profiles

14.2.1. Allergan

14.2.2. Otsuka Holdings Co., Ltd

14.2.3. Janssen Pharmaceutica (Johnson & Johnson)

14.2.4. Pfizer Inc.

14.2.5. Maynepharma

14.2.6. Vanda Pharmaceuticals Inc.

14.2.7. Sumitomo Dainippon Pharma

14.2.8. Eli Lilly & Co.

14.2.9. AstraZeneca Plc

For more information about this report visit https://www.researchandmarkets.com/r/6g81p9

View source version on businesswire.com:https://www.businesswire.com/news/home/20200207005156/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 02/07/2020 04:37 AM/DISC: 02/07/2020 04:37 AM

http://www.businesswire.com/news/home/20200207005156/en